Komori
Precision System Science (7707) · InitiativeAchieved

Covering the deficit through a reduction in capital reserve and securing flexibility in capital policy

First written in FY2021. 3 of 6 entries say "Achieved", first in FY2022-Q1. Latest entry: FY2026-H1.

6entries
6years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAchievedFY2022-Q1 – FY2026-H12021: 220212022: 020222023: 220232024: 020242025: 120252026: 1
Same theme, other companies
Capital Policy and Dividend Preparation through Capital Reduction and Deficit EliminationA theme 287 companies write about · 1 as a headwind · 286 as a tailwind
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 200 companies compared. The sentences above are computed from all 200.Comparing 200 of the theme's 289 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026-H1AchievedAnnual report

    「At the Annual General Meeting of Shareholders held on 26 September 2025, we resolved to dispose of other capital surplus, and the resolution took effect on 29 September 2025. As a result, ¥2,421,057 thousand of other capital surplus was transferred to retained earnings brought forward to offset the deficit.」

    The deficit offset using other capital surplus resolved in FY2025 took effect on 29 September 2025, and the transfer of ¥2,421,057 thousand was carried out.
  2. FY2025AdvancedAnnual report

    「We will offset the deficit in retained earnings brought forward by transferring other capital surplus to retained earnings brought forward.」

    Following the previous deficit offset through a reduction in capital reserves, the General Meeting of Shareholders approved the transfer of ¥2,421,057,962 in other capital surplus to retained earnings brought forward to offset the deficit.
  3. FY2024-Q1AchievedAnnual report

    「Amount of capital to be reduced: Of the capital of ¥4,643,722,217, ¥4,543,722,217 was reduced and the entire reduction was transferred to other capital surplus, leaving capital of ¥100,000,000 after the reduction. Effective date: 7 November 2023」

    The reduction of capital resolved in FY2023 took effect on 7 November 2023, completing the reduction of capital without compensation to ¥100 million.
  4. FY2023AdvancedAnnual report

    「Of the capital of ¥4,643,722,217, we will reduce ¥4,543,722,217 and transfer the entire reduction to other capital surplus, leaving capital of ¥100,000,000 after the reduction.」

    Following the previous reduction of capital reserves and deficit offset, a resolution was passed to reduce capital to ¥100 million and transfer the reduction to other capital surplus. The effective date was set as 7 November 2023, reaffirming the aim of securing flexibility and agility in capital policy.
  5. FY2022-Q1AchievedAnnual report

    「Based on a resolution at the 36th Annual General Meeting of Shareholders held on 28 September 2021, we reduced the amount of capital reserves and transferred the entire reduction to other capital surplus. We also appropriated a portion of other capital surplus and the entire amount of the legal reserve to offset the deficit by transferring them to retained earnings brought forward. In addition, we paid dividends funded by other capital surplus.」

    The reduction of ¥2,678,527 thousand in capital reserves, transfers to other capital surplus and retained earnings brought forward to offset the deficit, and dividends funded by capital surplus were carried out on 29 September 2021.
  6. FY2021First statedAnnual report

    「To offset the deficit and secure flexibility and agility in future capital policy, we will reduce the amount of capital reserves and dispose of retained earnings.」

    Following a resolution at the General Meeting of Shareholders on 28 September 2021, a plan was presented to transfer ¥2,678,527 thousand in capital reserves to other capital surplus and, of that amount, transfer ¥1,253,633 thousand to retained earnings brought forward to offset the deficit.
Moved together

"Expansion from an equipment-centered business into the reagent and diagnostic reagent businesses" moved the same way as this thread, in the same document, in 3 of its 6 moves.

333222★123456
  1. ★This thread
  2. 1Expansion from an equipment-centered business into the reagent and diagnostic reagent businesses3×
  3. 2Dependence of sales on the automated DNA extraction system3×
  4. 3Recurring Losses, Negative Operating Cash Flow and an Early Return to Profitability3×
  5. 4Fundamental Business Structure Reform and Earnings Improvement Measures2×
  6. 5Expansion into Clinical Diagnostics Using the Fully Automated geneLEAD Genetic Diagnostic Instrument2×
  7. 6Expansion of production capacity for reagents and consumables using funds from the capital increase2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Precision System Science yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Covering the deficit through a reduction in capital reserve and securing flexibility in capital policy | Precision System Science Co.,Ltd. (7707) | Komori